Skip to content

Laparoscopic endoscopic cooperative surgery for the duodenal neuroendocrine tumor

Laparoscopic endoscopic cooperative surgery for the duodenal neuroendocrine tumor

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN38499247
Enrollment
30
Registered
2023-04-15
Start date
2018-09-07
Completion date
Unknown
Last updated
2023-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duodenal neuroendocrine tumor Cancer

Interventions

3) confined to the mucosal or submucosal layer on EUS
4) absence of regional or distant lymph node metastases on imaging
Patients with D-NET who had LECS had their medical records retrospectively evaluated. Enhanced computed tomography (CT) scan and upper gastrointestinal (GI) endoscopy with biopsy were required for rou
2) tumor diameter no greater than 10 mm
5) non-ampullary NETs. Endoscopic procedure Generally, LECS was performed through collaboration between the surgical team and endoscopists. The same skilled endoscopis

Sponsors

Chinese Academy of Medical Sciences & Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Biopsy showed NET in the duodenum 2. Aged 20-80 years old 3. Agree to have LECS

Exclusion criteria

Exclusion criteria: Lost to follow-up

Design outcomes

Primary

MeasureTime frame
En bloc resection rate measured using pathology at 1 month after surgery

Secondary

MeasureTime frame
1. Absence of involvement of the lateral or vertical margins measured using pathology at 1 month after surgery 2. Absence of lymphovascular invasion measured using pathology at 1 month after surgery

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026